Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Kareg Corporation Initiates Coverage On GenSpera (OTCQB:GNSZ) With A Speculative Buy Recommendation

|Includes: Inspyr Therapeutics, Inc. (NSPX)

GenSpera, Inc. (OTCQB:GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces that Kareg Corporation's Director of Research, Sheldon S. Traube, has issued the following research report on the company.